Related Experiment Video
Updated: May 15, 2026

06:04
Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
[Unusual pneumonia by Pasteurella multocida].
J Duhautois1, J Chabrol, G Terce
1Service de pneumologie, centre hospitalier Béthune, rue Delbecque, 62408 Béthune, France.
Revue De Pneumologie Clinique
|January 22, 2013
Summary
Pasteurella multocida pneumonia can occur without direct inoculation, even in immunocompromised individuals. This case highlights a potential alternative transmission route for this common bacterial infection, often associated with cats.
Area of Science:
- Infectious Diseases
- Bacteriology
- Pulmonology
Background:
- Pasteurellosis is typically caused by Pasteurella multocida, often transmitted via animal bites or scratches.
- Cats are identified as primary vectors for Pasteurella multocida.
- Immunocompromised states elevate the risk of developing systemic Pasteurella infections.
Observation:
- A case of Pasteurella multocida pneumonia in an 81-year-old patient with no apparent skin inoculation site is presented.
- The patient had a history of treated rectal and prostate neoplasia, increasing susceptibility.
- A domestic cat in the household was noted as an environmental risk factor.
Findings:
- Diagnosis was confirmed through serial blood cultures.
- The patient showed significant clinical, biological, and radiological improvement following antimicrobial therapy.
- This case suggests a potential non-inoculation pathogenesis for Pasteurella multocida pneumonia.
Implications:
- The findings challenge the conventional understanding of Pasteurella multocida transmission routes.
- Further research into alternative infection pathways, particularly in vulnerable populations, is warranted.
- This case underscores the importance of considering environmental exposures, like pet ownership, in the context of atypical infections.
Related Concept Videos
Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
